RegenCell BioScience Holdings (RGC)

[shinhari1309]

RGC share buyback by Company CEO/Philanthropist

RGC a healthcare company which has been on the target of shortsellers in Q2 22’ is taking on the full might of the company CEO.

Based on the the CEO’s Schedule 13D fillings with the SEC (US Security and Exchange Commission), CEO (Mr Au) has used an aggregate of $5.03 mil of his personal funds to purchase ordinary shares on open market between July 2021 and May 2022. A total of 10,539,159 ordinary shares are now owned by the Mr Au, which represents approximately 81% of company’s total issued and outstanding ordinary shares.

The company’s mission is to develop a natural treatment method for neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people’s immune system such as COVID-19.

Aside from RGC’s approach in developing successful treatments for ADHD and ASD, Mr Au is also been involved in his own philanthropic project (within his own means) and aims to provided care to over 10,000 affected children with ADHD, ASD and Covid-19 and also those affected by financial difficulties. As of today, Mr Au’s project has personally helped over 150 children since the launch of this project on April 16, 22.